[ Citation in PubMed ] [ Related Articles ]
Ian Y.R. Adamson
Department of Pathology, University of Manitoba, Winnipeg, Canada
Key words : lung, mesothelial cells, asbestos, pleural disease
This paper is based on a presentation at The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles held 15-18 September 1996 in Lake Placid, New York. Manuscript received at EHP 27 March 1997; accepted 6 May 1997.This research project was supported by a grant from the Medical Research Council of Canada.
Address correspondence to Dr. I.Y.R. Adamson, Department of Pathology, University of Manitoba, D212-770 Bannatyne Avenue, Winnipeg, Canada R3E 0W3. Telephone: (204) 789-3539. Fax: (204) 774-9018. E-mail: iadamsn@cc.umanitoba.ca
Abbreviations used: AM, alveolar macrophage(s); BALF, bronchoalveolar lavage fluid(s); DMEM, Dulbecco's modified essential medium; EGF, epidermal growth factor; FGFa, FGFb, fibroblast growth factor(s); 3 HT, tritiated thymidine; KGF, FGF-7, keratinocyte growth factor; MC, mesothelial cell(s); PDGF, platelet-derived growth factor; PLLF, pleural lavage fluid(s); PLM, pleural macrophage(s); PM, pleural macrophage(s); TGF-
, TGF-ß, transforming growth factors; TNF-
, tumor necrosis factor.
Last Update: October 30, 1997